These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6423789)

  • 21. Children with moderately elevated blood lead levels: a role for other diagnostic tests?
    Markowitz ME; Clemente I; Rosen JF
    Environ Health Perspect; 1997 Oct; 105(10):1084-8. PubMed ID: 9349832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels.
    Moel DI; Kumar K
    Pediatrics; 1982 Aug; 70(2):259-62. PubMed ID: 7099793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate lead poisoning: trends in blood lead levels in unchelated children.
    Markowitz ME; Bijur PE; Ruff HA; Balbi K; Rosen JF
    Environ Health Perspect; 1996 Sep; 104(9):968-72. PubMed ID: 8899376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of CaNa2EDTA and chelation of lead in renal failure.
    Osterloh J; Becker CE
    Clin Pharmacol Ther; 1986 Dec; 40(6):686-93. PubMed ID: 3096624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressed excretion of 6 beta-hydroxycortisol in lead-toxic children.
    Saenger P; Markowitz ME; Rosen JF
    J Clin Endocrinol Metab; 1984 Feb; 58(2):363-7. PubMed ID: 6420437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple protoporphyrin assay-microhematocrit procedure as a screening technique for increased lead absorption in young children.
    Chisolm JJ; Mellits ED; Keil JE; Barrett MB
    J Pediatr; 1974 Apr; 84(4):490-6. PubMed ID: 4834244
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo inhibition of serum dopamine-beta-hydroxylase by CaNa2 EDTA injection.
    De Paris P; Caroldi S
    Hum Exp Toxicol; 1994 Apr; 13(4):253-6. PubMed ID: 8204310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of lead poisoning.
    Chisolm JJ
    Mod Treat; 1971 Aug; 8(3):593-611. PubMed ID: 5001054
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical responses to provocative chelation by edetate disodium calcium.
    Teisinger J
    Arch Environ Health; 1971 Oct; 23(4):280-3. PubMed ID: 4999977
    [No Abstract]   [Full Text] [Related]  

  • 30. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead poisoning risk determination in an urban population through the use of a standardized questionnaire.
    Schaffer SJ; Szilagyi PG; Weitzman M
    Pediatrics; 1994 Feb; 93(2):159-63. PubMed ID: 8121724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte hypoplasia due to lead poisoning: a devastating, yet curable disease.
    Moosa A; Harris F
    Clin Pediatr (Phila); 1969 Jul; 8(7):400-2. PubMed ID: 4978874
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluorescence of erythrocytes in relation to erythrocyte protoporphyrin and to urinary lead excretion.
    Nelson JD; Dorn P; Rogers LE; Sartain P
    Am J Clin Pathol; 1968 Sep; 50(3):297-301. PubMed ID: 4970982
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison between two diagnostic tests for lead poisoning.
    Blumenthal S; Davidow B; Harris D; Oliver-Smith F
    Am J Public Health; 1972 Aug; 62(8):1060-4. PubMed ID: 5046445
    [No Abstract]   [Full Text] [Related]  

  • 36. CaEDTA vs CaEDTA plus BAL to treat children with elevated blood lead levels.
    O'Connor ME
    Clin Pediatr (Phila); 1992 Jul; 31(7):386-90. PubMed ID: 1617861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick.
    Schonfeld DJ; Cullen MR; Rainey PM; Berg AT; Brown DR; Hogan JC; Turk DS; Rude CS; Cicchetti DV
    Pediatrics; 1994 Aug; 94(2 Pt 1):174-9. PubMed ID: 8036069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.
    Chisolm JJ
    Environ Health Perspect; 1990 Nov; 89():67-74. PubMed ID: 1965166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using state lead poisoning surveillance system data to assess false positive results of capillary testing.
    Anderson MK; Amrich M; Decker KL; Mervis CA
    Matern Child Health J; 2007 Nov; 11(6):603-10. PubMed ID: 17340181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of children suffering from lead poisoning or at risk of lead poisoning in Greater Paris, 1992--2002.
    Rollin L; Carré N; Garnier R;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):391-7. PubMed ID: 19013038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.